| Sensitive detection of mono-and polyclonal ESR1 mutations in primary tumors, metastatic lesions, and cell-free DNA of breast cancer patients P Wang, A Bahreini, R Gyanchandani, PC Lucas, RJ Hartmaier, ... Clinical cancer research 22 (5), 1130-1137, 2016 | 219 | 2016 |
| Intrinsic subtype switching and acquired ERBB2/HER2 amplifications and mutations in breast cancer brain metastases N Priedigkeit, RJ Hartmaier, Y Chen, D Vareslija, A Basudan, RJ Watters, ... JAMA oncology 3 (5), 666-671, 2017 | 165 | 2017 |
| Use of liposomes as drug delivery vehicles for treatment of melanoma MA Tran, RJ Watts, GP Robertson Pigment cell & melanoma research 22 (4), 388-399, 2009 | 148 | 2009 |
| Exome-capture RNA sequencing of decade-old breast cancers and matched decalcified bone metastases N Priedigkeit, RJ Watters, PC Lucas, A Basudan, R Bhargava, W Horne, ... JCI insight 2 (17), 2017 | 114 | 2017 |
| Targeting of survivin by nanoliposomal ceramide induces complete remission in a rat model of NK-LGL leukemia X Liu, L Ryland, J Yang, A Liao, C Aliaga, R Watts, SF Tan, J Kaiser, ... Blood, The Journal of the American Society of Hematology 116 (20), 4192-4201, 2010 | 109 | 2010 |
| Recurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancer RJ Hartmaier, SE Trabucco, N Priedigkeit, JH Chung, CA Parachoniak, ... Annals of oncology 29 (4), 872-880, 2018 | 107 | 2018 |
| Targeting sphingosine-1-phosphate receptors in cancer R J Watters, HG Wang, SS Sung, T P Loughran, X Liu Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2011 | 59 | 2011 |
| FGFR4 overexpression and hotspot mutations in metastatic ER+ breast cancer are enriched in the lobular subtype KM Levine, N Priedigkeit, A Basudan, N Tasdemir, MJ Sikora, ES Sokol, ... NPJ breast cancer 5 (1), 19, 2019 | 56 | 2019 |
| Cysteine string protein promotes proteasomal degradation of the cystic fibrosis transmembrane conductance regulator (CFTR) by increasing its interaction with the C terminus of … BZ Schmidt, RJ Watts, M Aridor, RA Frizzell Journal of Biological Chemistry 284 (7), 4168-4178, 2009 | 56 | 2009 |
| Therapeutic efficacy of FTY720 in a rat model of NK-cell leukemia A Liao, K Broeg, T Fox, SF Tan, R Watters, MV Shah, LQ Zhang, Y Li, ... Blood, The Journal of the American Society of Hematology 118 (10), 2793-2800, 2011 | 53 | 2011 |
| T-cell and natural killer-cell large granular lymphocyte leukemia neoplasias RJ Watters, X Liu, TP Loughran Jr Leukemia & lymphoma 52 (12), 2217-2225, 2011 | 46 | 2011 |
| Development and use of ceramide nanoliposomes in cancer RJ Watters, M Kester, MA Tran, TP Loughran Jr, X Liu Methods in enzymology 508, 89-108, 2012 | 42 | 2012 |
| Targeting glucosylceramide synthase synergizes with C6-ceramide nanoliposomes to induce apoptosis in natural killer cell leukemia RJ Watters, TE Fox, SF Tan, S Shanmugavelandy, JE Choby, K Broeg, ... Leukemia & lymphoma 54 (6), 1288-1296, 2013 | 41 | 2013 |
| Frequent ESR1 and CDK pathway copy-number alterations in metastatic breast cancer A Basudan, N Priedigkeit, RJ Hartmaier, ES Sokol, A Bahreini, RJ Watters, ... Molecular Cancer Research 17 (2), 457-468, 2019 | 40 | 2019 |
| Tumor resection guided by intraoperative indocyanine green dye fluorescence angiography results in negative surgical margins and decreased local recurrence in an orthotopic … A Mahjoub, A Morales-Restrepo, MS Fourman, JB Mandell, L Feiqi, ... Annals of surgical oncology 26, 894-898, 2019 | 26 | 2019 |
| Ewing sarcoma and osteosarcoma have distinct immune signatures and intercellular communication networks AR Cillo, E Mukherjee, NG Bailey, S Onkar, J Daley, C Salgado, X Li, ... Clinical Cancer Research 28 (22), 4968-4982, 2022 | 25 | 2022 |
| Disulfiram reduces metastatic osteosarcoma tumor burden in an immunocompetent Balb/c or-thotopic mouse model JA Crasto, MS Fourman, A Morales-Restrepo, A Mahjoub, JB Mandell, ... Oncotarget 9 (53), 30163, 2018 | 18 | 2018 |
| Combination Therapy with Disulfiram, Copper, and Doxorubicin for Osteosarcoma: In Vitro Support for a Novel Drug Repurposing Strategy JB Mandell, F Lu, M Fisch, JH Beumer, J Guo, RJ Watters, KR Weiss Sarcoma 2019 (1), 1320201, 2019 | 17 | 2019 |
| Single cell heterogeneity and evolution of breast cancer bone metastasis and organoids reveals therapeutic targets for precision medicine K Ding, F Chen, N Priedigkeit, DD Brown, K Weiss, R Watters, KM Levine, ... Annals of Oncology 33 (10), 1085-1088, 2022 | 11 | 2022 |
| Avenues of research in dietary interventions to target tumor metabolism in osteosarcoma TC Leite, RJ Watters, KR Weiss, G Intini Journal of Translational Medicine 19 (1), 450, 2021 | 11 | 2021 |
Kurt WeissAssistant Professor, University of Pittsburgh School of MedicineVerified email at upmc.edu
